# EXCEDRIN (MIGRAINE RELIEF)
> **NDA020802** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 1998-01-14
## Drug
- **FDA Application Number:** NDA020802
- **Application type:** New Drug Application
- **Brand name:** EXCEDRIN (MIGRAINE RELIEF)
- **Generic name:** ACETAMINOPHEN, ASPRIN, CAFFEINE
- **Active ingredients:** ACETAMINOPHEN; ASPIRIN; CAFFEINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HALEON US HOLDINGS
- **Manufacturer:** Haleon US Holdings LLC
- **First approval:** 1998-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020802)
---
*MORVS · CC0 1.0*